NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

生物晶片的市場預測、競爭趨勢、成長機會 (∼2026年):各技術、類型、用途、終端用戶、地區

Global Biochip Market, By Technology, By Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026

出版商 TechSci Research 商品編碼 1002700
出版日期 內容資訊 英文 206 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

生物晶片的市場預測、競爭趨勢、成長機會 (∼2026年):各技術、類型、用途、終端用戶、地區 Global Biochip Market, By Technology, By Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026
出版日期: 2021年07月01日內容資訊: 英文 206 Pages
簡介

全球生物晶片的市場規模2020年表現116億9424萬美元的規模,預計2026年成長到238億9058萬美元的規模。

各種慢性疾病和感染疾病的擴大,尤其是癌症等疾病的個人化醫療和標靶治療的需求擴大,R&D的活躍,政府的輔助政策等要素促進該市場的成長。同時,生物晶片的成本高,新興各國的認知度低,各國政府的嚴格法律規章等要素妨礙市場進一步成長。

本報告提供全球生物晶片的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,技術、類型、用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 產品概要

第2章 調查手法

第3章 COVID-19的影響

第4章 客戶的迴響

第5章 摘要整理

第6章 全球市場預測

  • 市場規模、預測
  • 市場佔有率、預測
  • 各技術
    • 微陣列
    • 微射流
  • 各類型
    • DNA晶片
    • 實驗室晶片
    • 蛋白質晶片
    • 其他
  • 各用途
    • 藥物研發、開發
    • 疾病診斷
    • 基因學
    • 蛋白質體學
    • 其他
  • 各終端用戶
    • 生物&製藥企業
    • 醫院、診斷中心
    • 學術、研究機關
    • 其他
  • 各企業
  • 各地區
  • 產品市場地圖

第7章 北美市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
  • 各技術
  • 各類型
  • 各用途
  • 各終端用戶
  • 各國

第8章 歐洲市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
  • 各技術
  • 各類型
  • 各用途
  • 各終端用戶
  • 各國

第9章 亞太地區市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
  • 各技術
  • 各類型
  • 各用途
  • 各終端用戶
  • 各國

第10章 南美市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
  • 各技術
  • 各類型
  • 各用途
  • 各終端用戶
  • 各國

第11章 中東、非洲市場分析、預測

  • 市場規模、預測
  • 市場佔有率、預測
  • 各技術
  • 各類型
  • 各用途
  • 各終端用戶
  • 各國

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • 競爭的展望
  • 企業簡介

第15章 策略性建議

第16章 關於本公司、免責聲明

目錄
Product Code: 1259

Global biochip market was valued at USD11694.24 million in 2020 and is expected to reach USD23890.58 million by 2026, registering a CAGR of 12.52% in the next five years. The global biochip market is driven by the growing prevalence of various chronic and infectious diseases especially in the geriatric population who are more susceptible to these diseases on account of low immunity. This has led to the increase in demand for personalized medicine solutions or targeted therapies especially for diagnosis and treatment of diseases like cancer. This in turn is expected to positively influence the market growth over the next few years. Additionally, increasing R&D activities and supportive government policies further propels the market. However, the high cost of biochips can hamper market growth. Moreover, lack of awareness, especially in the developing and underdeveloped countries, further impedes the market growth.

The global biochip market is segmented based on technology, type, application, end user, company, and region. Based on technology, the market can be bifurcated into microarray and microfluidics. The microarray technology dominated the market in 2020 with a share of around 60.22% and is expected to dominate the market during the forecast period also. This can be attributed to the extensive use of biochips in forensic analysis and identification of drug candidates in the drug discovery process. While the microfluidics technology is expected to witness significant growth over the next few years on account of the increasing use of point of care diagnostic devices such as pregnancy kits, cardiac makers, and blood gases, among others. Based on type, the market can be categorized into DNA Chips, Lab-On-a-Chips, Protein Chips and others. The DNA chips segment is expected to dominate the market during the forecast period. This can be ascribed to the widespread adoption of DNA chips. Additionally, growing expenditure related to genomics and next-generation sequencing along with rising demand for detection and diagnosis of genetic disorders is further expected to support the market growth.

Regionally, North America represented a major share of the global market and is anticipated to continue its dominance in the forecast period. This is directly related to a rise in cancer incidence in the region. In 2020, cancers such as, prostate, lung, and colorectal accounted for approximately 43% of all cancers diagnosed in men. In case of women, breast, lung, and colorectal cancers are the most common cancers and they account for an estimated 50% of all new cancer diagnosed in women in the year 2020. Additionally, growing burden of different diseases is further expected to fuel the market growth.

The major players operating in the global biochip market are Abbott Laboratories Ltd., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, BioMerieux SA, HORIBA, Ltd., QIAGEN N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., Cepheid (Danaher Corporation) and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers and acquisitions and new product developments. For instance, In March 2020, Agilent Technologies, Inc. developed three new GenetiSure Cyto microarrays for prenatal and postnatal research.

Years considered for this report:

  • Historical Year: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the global biochip market from 2016 to 2020.
  • To estimate and forecast the market size of the global biochip market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the global biochip market based on type, technology, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the global biochip market.
  • To identify drivers and challenges for the global biochip market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global biochip market.
  • To conduct pricing analysis for the global biochip market.
  • To identify and analyze the profile of leading players operating in the global biochip market.
  • To identify key sustainable strategies adopted by market players in the global biochip market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global biochip market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Biochip manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to biochips

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global biochip market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Biochip Market, By Technology:

  • Microarray
  • Microfluidics

Global Biochip Market, By Type:

  • DNA Chips
  • Lab-On-a-Chips
  • Protein Chips
  • Others

Global Biochip Market, By Application:

  • Drug Discovery & Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • Others

Global Biochip Market, By End User:

  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Others

Global Biochip Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global biochip market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Biochip Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Major Benefits of Using Biochips
  • 5.3. Preferred Biochips, Based on Technology

6. Global Biochip Market Outlook, 2016-2026F

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology (Microarray v/s Microfluidics)
    • 6.2.2. By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others)
    • 6.2.3. By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others)
    • 6.2.4. By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2020)
  • 6.3. Product Market Map

7. North America Biochip Market Outlook, 2016-2026F

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Biochip Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Biochip Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Biochip Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Biochip Market Outlook, 2016-2026F

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. United Kingdom Biochip Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Biochip Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. France Biochip Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Biochip Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Biochip Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Biochip Market Outlook, 2016-2026F

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Biochip Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Japan Biochip Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. India Biochip Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Biochip Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Technology
        • 9.3.4.2.2. By Type
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Biochip Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Technology
        • 9.3.5.2.2. By Type
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Biochip Market Outlook, 2016-2026F

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biochip Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Biochip Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Biochip Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Biochip Market Outlook, 2016-2026F

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Type
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Biochip Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Technology
        • 11.3.1.2.2. By Type
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Biochip Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Technology
        • 11.3.2.2.2. By Type
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Biochip Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Technology
        • 11.3.3.2.2. By Type
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Abbott Laboratories Inc.
    • 14.2.2. Agilent Technologies, Inc.
    • 14.2.3. PerkinElmer Inc.
    • 14.2.4. Fluidigm Corporation
    • 14.2.5. Illumina, Inc.
    • 14.2.6. GE Healthcare Inc.
    • 14.2.7. Bio-Rad Laboratories Inc.
    • 14.2.8. Thermo Fisher Scientific, Inc.
    • 14.2.9. F. Hoffmann-La Roche AG
    • 14.2.10. BioMerieux SA
    • 14.2.11. HORIBA, Ltd.
    • 14.2.12. QIAGEN N.V.
    • 14.2.13. Randox Laboratories Ltd.
    • 14.2.14. OriGene Technologies, Inc.
    • 14.2.15. Cepheid (Danaher Corporation)

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Research & Development Expenditure of Top 5 Countries (USD Billion), As of 2021
  • Figure 3: Global Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 4: Global Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 5: Global Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 6: Global Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 7: Global Biochip Market Share, By Region, By Value, 2016-2026F
  • Figure 8: Global Biochip Market Share, By Company, By Value, 2020
  • Figure 9: Global Biochip Market Map, By Technology, Market Size (USD Million) & Growth Rate (%)
  • Figure 10: Global Biochip Market Map, By Type, Market Size (USD Million) & Growth Rate (%)
  • Figure 11: North America Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 12: North America Undiagnosed and Diagnosed Diabetes Cases, 2019
  • Figure 13: North America Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 14: North America Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 15: North America Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 16: North America Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 17: North America Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 18: United States Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 19: New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages
  • Figure 20: United States Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 21: United States Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 22: United States Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 23: United States Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 24: Canada Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 25: Canada Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 26: Canada Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 27: Canada Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 28: Canada Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 29: Canada Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 30: Mexico Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 31: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 32: Mexico Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 33: Mexico Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 34: Mexico Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 35: Mexico Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 36: Europe Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 37: Leading Cancers in Males in Europe by Incidence and Mortality Common Cancers, 2020
  • Figure 38: Europe Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 39: Europe Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 40: Europe Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 41: Europe Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 42: Europe Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 43: United Kingdom Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 44: Geriatric Population Numbers & Projections in United Kingdom (Millions), 2020
  • Figure 45: United Kingdom Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 46: United Kingdom Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 47: United Kingdom Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 48: United Kingdom Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 49: Germany Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 50: Germany New Cancer Cases, By Type, 2020
  • Figure 51: Germany Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 52: Germany Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 53: Germany Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 54: Germany Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 55: France Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 56: France Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 57: France Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 58: France Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 59: France Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 60: France Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 61: Italy Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 62: Italy Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 63: Italy Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 64: Italy Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 65: Italy Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 66: Italy Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 67: Spain Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 68: Number of New Cancer Cases in Spain, By Cancer Site, 2020
  • Figure 69: Spain Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 70: Spain Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 71: Spain Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 72: Spain Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 73: Asia Pacific Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 74: Number of New Cancer Cases in Asia Pacific (2020)
  • Figure 75: Asia Pacific Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 76: Asia Pacific Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 77: Asia Pacific Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 78: Asia Pacific Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 79: Asia Pacific Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 80: China Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 81: China Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 82: China Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 83: China Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 84: China Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 85: China Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 86: Japan Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 87: Japan Total Health Expenditure as a share of GDP, 2015- 2019
  • Figure 88: Japan Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 89: Japan Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 90: Japan Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 91: Japan Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 92: India Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 93: Growing Share of Geriatric Population (Above 60 Years) in India (2015-2019)
  • Figure 94: India Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 95: India Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 96: India Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 97: India Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 98: South Korea Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 99: New Cancer Cases in South Korea (%), 2019
  • Figure 100: South Korea Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 101: South Korea Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 102: South Korea Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 103: South Korea Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 104: Australia Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 105: Australia Forensic Technology Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 106: Australia Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 107: Australia Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 108: Australia Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 109: Australia Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 110: South America Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 111: Central and South America Diagnosed and Undiagnosed Diabetes Cases, 2019
  • Figure 112: South America Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 113: South America Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 114: South America Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 115: South America Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 116: South America Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 117: Brazil Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 118: Brazil Healthcare Spending, By Value (USD Per Capita), 2015-2019
  • Figure 119: Brazil Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 120: Brazil Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 121: Brazil Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 122: Brazil Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 123: Argentina Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 124: Argentina Bioinformatics Market Size, By Value (USD Billion), 2016-2026F
  • Figure 125: Argentina Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 126: Argentina Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 127: Argentina Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 128: Argentina Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 129: Colombia Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 130: New Cancer Cases in Colombia (%), 2019
  • Figure 131: Colombia Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 132: Colombia Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 133: Colombia Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 134: Colombia Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 135: Middle East & Africa Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 136: Middle East & Africa Geriatric Population Base (Age 60 & Above) % of Total Population, 2015-2019
  • Figure 137: Middle East & Africa Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 138: Middle East & Africa Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 139: Middle East & Africa Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 140: Middle East & Africa Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 141: Middle East & Africa Biochip Market Share, By Country, By Value, 2016-2026F
  • Figure 142: South Africa Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 143: South Africa New Cancer Cases, By Type, 2020
  • Figure 144: South Africa Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 145: South Africa Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 146: South Africa Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 147: South Africa Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 148: Saudi Arabia Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 149: Saudi Arabia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 150: Saudi Arabia Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 151: Saudi Arabia Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 152: Saudi Arabia Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 153: Saudi Arabia Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 154: UAE Biochip Market Size, By Value (USD Million), 2016-2026F
  • Figure 155: % of female population in UAE, 2015-2019
  • Figure 156: UAE Biochip Market Share, By Technology, By Value, 2016-2026F
  • Figure 157: UAE Biochip Market Share, By Type, By Value, 2016-2026F
  • Figure 158: UAE Biochip Market Share, By Application, By Value, 2016-2026F
  • Figure 159: UAE Biochip Market Share, By End User, By Value, 2016-2026F
  • Figure 160: Global Population Ages 65 & Above (% of Total Population), 2016-2019
  • Figure 161: Number of Deaths Caused due to Selected Chronic Diseases in 2019 (in Thousands)